Aller au contenu principal Activer le contraste adaptéDésactiver le contraste adapté
Plus de 40 000 produits accessibles à 0€ de frais de courtage
Découvrir Boursomarkets
Fermer

NATUREX : Half-year summaryof NATUREX's liquidity contract, June 2014
information fournie par Actusnews 10/07/2014 à 20:00

Pursuant to the liquidity contract granted to EXANE BNP PARIBAS regarding NATUREX shares, the following elements were in the liquidity account as of June 30, 2014, negotiation date:
  • 4,853 NATUREX shares
  • 850 Subscription rights
  • 523,937.00 euros
It is reminded that the following assets appeared on the liquidity account as of December 31, 2013, settlement date:
  • 8,642 NATUREX shares
  • 269,721.00 euros


If you would like to receive financial information about Naturex by e-mail, go to: www.naturex.com



Naturex has been listed on Euronext Paris, Compartment B (MidCaps), since October 1996.
Total number of shares comprising the share capital: 9,182,307
ISIN FR0000054694
Naturex is a component of the CAC Small and Gaïa indexes.
Naturex is eligible for "long only" Deferred Settlement Service (SRD).
Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.
SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY


About NATUREX
NATUREX is the global leader in specialty plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
NATUREX is the global leader in specialty plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

Contacts
Thierry Lambert
Chair and Chief Executive Officer
Tel.: +33 (0)4 90 23 96 89
t.lambert@naturex.com
Thierry-Bertrand Lambert
Chief Financial Officer
Tel.: +33 (0)4 90 23 96 89
t.b.lambert@naturex.com
Carole Alexandre
Investor Relations
Tel.: +33 (0)4 90 23 78 28
c.alexandre@naturex.com
Anne Catherine Bonjour
Actus Finance Press Relations
Tel.: +33 (0)1 53 67 36 93
acbonjour@actus.fr
Information réglementée
Rachat d'actions / contrat de liquidité :
- Information relative au contrat de liquidité Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-36582-Half-year-summary-of-NATUREX_s-liquidity-contract_June-2014.pdf

Valeurs associées

Euronext Paris 0.00%

0 commentaire

Signaler le commentaire

Fermer

Mes listes

Cette liste ne contient aucune valeur.